Last updated on February 2020

Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Subjects With Advanced HCC Who Have Not Received Previous Systemic Anticancer Therapy


Brief description of study

This Phase 3 study evaluates the safety and efficacy of cabozantinib in combination with atezolizumab versus the standard of care sorafenib in adults with advanced hepatocellular carcinoma (HCC) who have not received previous systemic anticancer therapy. A single-agent cabozantinib arm will be enrolled in which subjects receive single agent cabozantinib in order to determine its contribution to the overall safety and efficacy of the combination with atezolizumab.

Detailed Study Description

This is a multicenter, randomized, open-label, controlled Phase 3 trial of cabozantinib in combination with atezolizumab versus sorafenib in adults with advanced HCC who have not received previous systemic anticancer therapy in the advanced HCC setting. The primary objective of this study is to evaluate the effect of cabozantinib in combination with atezolizumab on the duration of progression-free survival (PFS) and duration of overall survival (OS) versus sorafenib. The secondary objective is to evaluate the activity of single-agent cabozantinib compared with sorafenib in this patient population.

Clinical Study Identifier: NCT03755791

Find a site near you

Start Over

Exelixis Clinical Site #2

Rialto, CA United States
  Connect »

Exelixis Clinical Site #1

Las Vegas, NV United States
  Connect »

Exelixis Clinical Site #4

Atlanta, GA United States
  Connect »

Exelixis Clinical Site #6

Baltimore, MD United States
  Connect »

Exelixis Clinical Site #7

Burlington, MA United States
  Connect »

Exelixis Clinical Site #5

Kansas City, MO United States
  Connect »

Exelixis Clinical Site #3

Spokane, WA United States
  Connect »

Exelixis Clinical Site #8

Saint Louis, MO United States
  Connect »

Exelixis Clinical Site #11

Kansas City, MO United States
  Connect »

Exelixis Clinical Site #14

New Brunswick, NJ United States
  Connect »

Exelixis Clinical Site #12

Chapel Hill, NC United States
  Connect »

Exelixis Clinical Site #13

Seattle, WA United States
  Connect »

Exelixis Clinical Site #44

La Jolla, CA United States
  Connect »

Exelixis Clinical Site #46

Seattle, WA United States
  Connect »

Exelixis Clinical Site #54

San Francisco, CA United States
  Connect »

Exelixis Clinical Site #58

Washington, WA United States
  Connect »

Exelixis Clinical Site #57

Haine-Saint-Paul, Belgium
  Connect »

Exelixis Clinical Site #112

Los Angeles, CA United States
  Connect »

Exelixis Clinical Site #109

San Francisco, CA United States
  Connect »

Exelixis Clinical Site #120

Chicago, IL United States
  Connect »

Exelixis Clinical Site #76

Albuquerque, NM United States
  Connect »

Exelixis Clinical Site #176

Portland, OR United States
  Connect »

Exelixis Clinical Site #88

Philadelphia, PA United States
  Connect »

Exelixis Clinical Site #144

Charleston, SC United States
  Connect »

Exelixis Clinical Site #154

Houston, TX United States
  Connect »

Exelixis Clinical Site #157

Goyang-si, Korea, Republic of
  Connect »

Exelixis Clinical Site #127

Suwon, Korea, Republic of
  Connect »

Exelixis Clinical Site #77

Busan, Korea, Republic of
  Connect »

Exelixis Clinical Site #86

Busan, Korea, Republic of
  Connect »

Exelixis Clinical Site #114

Busan, Korea, Republic of
  Connect »

Exelixis Clinical Site #75

Incheon, Korea, Republic of
  Connect »

Exelixis Clinical Site #104

Seoul, Korea, Republic of
  Connect »

Exelixis Clinical Site #105

Seoul, Korea, Republic of
  Connect »

Exelixis Clinical Site #99

Seoul, Korea, Republic of
  Connect »

Exelixis Clinical Site #79

Seoul, Korea, Republic of
  Connect »

Exelixis Clinical Site #93

Seoul, Korea, Republic of
  Connect »

Exelixis Clinical Site #74

Kislino, Russian Federation
  Connect »

Exelixis Clinical Site #81

Kaluga, Russian Federation
  Connect »

Exelixis Clinical Site #95

Krasnodar, Russian Federation
  Connect »

Exelixis Clinical Site #108

Moscow, Russian Federation
  Connect »

Exelixis Clinical Site #101

Murmansk, Russian Federation
  Connect »

Exelixis Clinical Site #80

Nizhny Novgorod, Russian Federation
  Connect »

Exelixis Clinical Site #111

Saint Petersburg, Russian Federation
  Connect »

Exelixis Clinical Site #90

Saint-Petersburg, Russian Federation
  Connect »

Exelixis Clinical Site #73

Sochi, Russian Federation
  Connect »

Exelixis Clinical Site #110

Saint Gallen, Switzerland
  Connect »

Exelixis Clinical Site #87

Cambridge, United Kingdom
  Connect »

Exelixis Clinical Site #18

Hradec Králové, Czechia
  Connect »

Exelixis Clinical Site #32

Vandœuvre-lès-Nancy, France
  Connect »

Exelixis Clinical Site #141

Tuxtla Gutiérrez, Mexico
  Connect »

Exelixis Clinical Site #133

Ciudad De México, Mexico
  Connect »

Exelixis Clinical Site #192

Manchester, United Kingdom
  Connect »